Jennifer Kempisty
Nurse Practitioner · Columbus, GANPI 1376097543
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $900 and has fallen 77.5% since, to $202 in 2025.
Across 113 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- Pfizer$245
- Hologic Sales And Service, LLC$211
- Biohaven Pharmaceutical Holding Company Ltd.$202
- Bayer$192
- Astellas Pharma US Inc$176
- plus $755 from 20 others
What the payments were for
- Food & beverage$2,14597%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $438 |
| Pfizer | 16 | $245 |
| Hologic Sales And Service, LLC | 13 | $211 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $202 |
| Bayer | 5 | $192 |
| Astellas Pharma US Inc | 6 | $176 |
| Teleflex LLC | 3 | $141 |
| Mayne Pharma Commercial LLC | 5 | $99 |
| Sumitomo Pharma America, Inc. | 6 | $97 |
| Exeltis, USA Inc. | 3 | $52 |
| Evofem Biosciences, Inc. | 3 | $47 |
| Coopersurgical, Inc. | 2 | $36 |
| Scynexis, Inc. | 2 | $35 |
| Vertex | 2 | $32 |
| Mylan Pharmaceuticals Inc. | 2 | $31 |
| Organon | 1 | $28 |
| Avion Pharmaceuticals | 2 | $25 |
| Tolmar Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $13 |
| Molnlycke Health Care US, LLC | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Myovant Sciences Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$122
- Nubeqa$118
How this compares
$2,220 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $991 |
| Fluconazole | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Columbus
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
- Luis PoloSavannah$70K
- Karen BauerDecatur$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.